IP Library Granted Patent US 9,006,420
Granted Patent B2
US 9,006,420 · App. 12/941,783 · Granted Apr 14, 2015

Method for concentrating and isolating biomolecules or viruses

Inventor: Timo Hillebrand (Hoppegarten, DE)
C12N15/1003C07K1/30C07K1/32C12N7/00C12N2770/24351
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,006,420
App. No.
12/941,783
Granted
Apr 14, 2015
Kind
B2
Abstract

A simple and convenient method for concentrating a biomolecule, including protein or nucleic acid molecules, from a sample. Purified and isolated biomolecules obtained by this method. Methods for improving the specificity or sensitivity of detecting a biomolecule by concentration and/or purification or isolation of the biomolecule according to the method of the invention.

Claims (14)

1. A method for concentrating or isolating a nucleic acid comprising:

a) contacting a sample containing the nucleic acid with an aqueous solution of at least one salt of a polyuronic acid to form a mixture;

b) adding at least one substance that induces gel formation of the at least one salt of the polyuronic acid in the mixture;

c) isolating the gel formed in (b) from liquid components of the mixture; and

d) recovering the nucleic acid from the isolated gel, thereby concentrating or isolating the nucleic acid.

2. The method of claim 1 , wherein the salt of the polyuronic acid is alginate.

3. The method of claim 1 , wherein said at least one substance that induces gel formation of the salt of the polyuronic acid is at least one acid, at least one solution containing calcium ions, or a combination thereof.

4. The method of claim 1 , comprising adding in (b) at least one calcium solution at a concentration of calcium ions of 1 mol/L.

5. The method of claim 1 , comprising adding in (b) at least one acid at a concentration of 1% w/v.

6. The method of claim 1 , wherein isolating the gel in (c) comprises centrifuging the sample and removing the supernatant.

7. The method of claim 1 , wherein the nucleic acid is recovered in (d) by dissolving the gel and isolating the nucleic acid from the dissolved gel.

8. The method of claim 1 , wherein the nucleic acid is recovered by dissolving the gel with at least one agent selected from the group consisting of an alkali, a chelating agent, and a chaotropic salt.

9. The method of claim 1 , wherein the nucleic acid is recovered by dissolving the gel with at least one compound selected from the group consisting of EDTA, a guanidinium salt, or a citrate.

10. The method of claim 1 , wherein the sample contains a virus and the virus is subjected to lysis prior to (a) or after (d).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2019
From: HILLEBRAND, TIMO
To: AJ INNUSCREEN GMBH
Reel/Frame 050252/0449 →
Priority Claims (1)
DE 10 2008 023 297 · May 8, 2008 · national
Continuity (2)
Continuation PCTEP2009055596 · May 8, 2009
Related Publication 20110117628A1 · May 19, 2011